Clinical trials
Phase 2 Heart Failure trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Novartis Pharmaceuticals | 2 |
| University Hospital, Akershus | 2 |
| Bio-Medisinsk Innovasjon | 1 |
| Cytokinetics | 1 |
| Haukeland University Hospital | 1 |
| IC TARGETS AS | 1 |
| Oslo University Hospital | 1 |
| Quantum Genomics SA | 1 |
| Torbjorn Omland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 13 |
| Breast Neoplasms | 3 |
| Cardiotoxicity | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyspnea | 1 |
| Heart Diseases | 1 |
| Heart Failure, Systolic | 1 |
| Hyperglycemia | 1 |
| Hypersensitivity | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.